Day: September 12, 2022

Venice Film Festival: The Web Series Artitude Created by Pomilio Blumm Receives an Award for Promoting the Made in Italy Brand

Lorenzo Balbi at the Venice Film Festival VENICE, Italy, Sept. 12, 2022 (GLOBE NEWSWIRE) — The prize awarded to the web series Artitude was presented in Venice as part of the Film Festival. The Social World Film Festival jury’s special plaque for the project created by Pomilio Blumm was received by Lorenzo Balbi, director of MAMbo (Museum […]

Read More

Mecobit Mining Rigs Announces the Biggest Hash-Rate in the Market

LONDON, Sept. 12, 2022 (GLOBE NEWSWIRE) — MECO Limited (Mecobit), one of the world’s leading manufacturers of solar modules and complete solutions, recently launched new products Solar Unit M4000, Solar Panel Kit (complete), Portable Power Station, M100 Miner, M200 Miner, Meco Rack, which has attracted wide attention in the industry. The result of five years […]

Read More

Neeyamo’s Global Screening Services is Now ScreenXchange – an Independent Business Unit Poised for Tremendous Growth

ScreenXchange provides a superior screening experience courtesy of its peerless delivery model. LOS GATOS, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Success in a rapidly evolving borderless business environment requires bleeding-edge employee screening to ensure you have the right talent with validated credentials that mitigates organizations from potential risks. Neeyamo is elated to announce the […]

Read More

Azerbaijani currency rates for September 12

BAKU, Azerbaijan, September 12. The official exchange rate of the US dollar and euro against Azerbaijani manat as of September 12, 2022 is set at 1.7 and 1.7139 manat, respectively, Trend reports via Central Bank of Azerbaijan (CBA). According to CBA the manat rate to other currencies on September 12 is as follows: Currencies Official exchange rate 1 US dollar USD 1.7 1 Euro EUR 1.7139 1 Australian dollar AUD 1.1612 1 Argentine peso ARS 0.012 1 Belarus ruble BYN 0.6734 1 Brazil real BRL 0.3302 1 UAE dirham AED 0.4628 1 South African rand ZAR 0.0982 100 South Korean won KRW 0.123

Read More

Bezos Rocket Fails During Liftoff, Only Experiments Aboard

Jeff Bezos’ rocket company suffered its first launch failure Monday. No one was aboard, only science experiments. The Blue Origin rocket veered off course over West Texas about a minute after liftoff. The capsule’s launch abort system immediately kicked in, lifting the craft off the top. Several minutes later, the capsule parachuted onto the remote desert floor. Blue Origin’s launch commentary went silent when the capsule catapulted off the rocket, later announcing: “It appears we’ve experienced an anomaly with today’s flight. This wasn’t planned.” The mishap occurred as the rocket was traveling nearly 700 mph (1,126 kph) at an altitude

Read More

EU Regulator Backs Pfizer’s Omicron-Adapted Vaccine Booster

The European Medicines Agency (EMA) on Monday recommended a COVID-19 booster designed to combat the currently circulating Omicron BA.4/5 subvariants, days after endorsing a pair of boosters tailored to target the older BA.1 Omicron variant. The latest recommendation is for a so-called bivalent vaccine developed by Pfizer PFE.N and BioNTech 22UAy.DE, which targets BA.4/5 as well as the strain of the virus that originally emerged in China in December 2019 targeted by earlier COVID vaccines. The EMA recommendation is to authorize the retooled booster shots for people aged 12 and above who have received at least primary vaccination against COVID.

Read More

Truth and justice: A conversation with the families of Flight PS752 victims

WASHINGTON, Sept. 12, 2022 (GLOBE NEWSWIRE) — When: 1:00 p.m. ET on Wednesday, September 14, 2022 Where: 1030 15th Street, NW, 12th Floor Washington, DC 20005 Registration and virtual attendance available via the link below: What: The Association of Families of Flight PS752 Victims (the Association) will be participating in a discussion hosted by […]

Read More

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that it has received approval to conduct a Phase 1 clinical study of an intravenous formulation (“IVF”) of AP-188 (“N,N-dimethyl tryptamine” or “DMT”) for […]

Read More

Recent Posts